Acrux Limited Price (ACR.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

289,499,999

(1.0608)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.024-0.099
  • Market Cap 10.18M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus
  • IPO Date: September, 29, 2004
  • Country: AU
  • Currency: AUD
  • Headquaters: West Melbourne, VIC
  • Employees: 43

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation